UPM Pharmaceuticals will acquire Pfizer‘s 500,000-sq.-ft. commercial manufacturing facility in Bristol, TN. The acquisition will provide UPM with large-scale commercial capabilities for manufacturing and packaging of solid oral dosage tablets and capsules, as well as semi-solid manufacturing of creams and ointments. The facility will also provide for comprehensive tech transfer support, pilot plant scale-up capabilities, analytical and microbial testing, as well as dedicated suites for po...